Abstract
Angina pectoris and acute myocardial infarction are the main cardiac manifestations of atherosclerosis. Atherosclerosis is a pathological condition that underlies several important disorders including coronary artery disease, cerebrovascular disease, and diseases of the aorta and peripheral arterial circulation. Since Edward Jenner first attributed angina pectoris to coronary artery disease in 1786, there is a growing understanding about the pathophysiology of coronary artery disease and its complications. The first coronary artery disease manifestation in women is more likely to be angina, whereas in men it more often presents as a myocardial infarction. Even after surviving the acute stage of myocardial infarction, the incidence of re- infarction, sudden death, angina pectoris and cardiac failure are all substantial. Further innovations in diagnosis and treatment of coronary disease will undoubtedly improve the outlook of patients surviving the initial attack.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Weitz Jl. Activation of blood coagulation by plaque rupture: mechanisms and prevention. Am J Cardiol 1995; 75:18B–22B.
Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO 3rd. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation 1995; 92:320–6.
Olsson RA, Bunger R. Metabolic control of coronary blood flow. Prog Cardiovasc Dis 1987; 29:369–87.
Canty JM Jr, Schwartz JS. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Circulation 1994; 89:375–84.
Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986; 250:H1145–9.
Vita JA, Treasure CB, Yeung AC, et al. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation 1992; 85:1390–7.
Vatner SF. Regulation of coronary resistance vessels and large coronary arteries. Am J Cardiol 1985; 56:16E–22E.
Cocks TM, Angus JA. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 1983; 305:627–30.
Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. Circulation 1990; 81:482–90.
Nobuyoshi M, Tanaka M, Nosaka H, et al. Progression of coronary atherosclerosis: is coronary spasm related to progression? J.Am.Coll.Cardiol. 1991; 18:904–10.
Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81:491–7.
Quyyumi AA, Dakak N, Andrews NP, et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 1995; 95:1747–55.
Zeiher AM, Drexler H, Saurbier B, JustI H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993; 92:652–62.
Ontkean M, Gay R, Greenberg B. Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure. Circ Res 1991; 69:1088–96.
Drexler H, Hayoz D, Munzel T, et al. Endothelial function in chronic congestive heart failure. Am J Cardiol 1992; 69:1596–601.
Treasure CB, Alexander RW. The dysfunctional endothelium in heart failure. J Am Coll Cardiol 1993; 22(4 Suppl A):129A–134A.
Drexler H, Hornig B. Importance of endothelial function in chronic heart failure. J Cardiovasc Pharmacol 1996; 27 Suppl 2:S9–12.
Steinberg HO, Bayazeed B, Hook G, Johnson A, Cronin J, Baron AD. Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation 1997; 96:3287–93.
Voors AA, Oosterga M, Buikema H, et al. Dyslipidemia and endothelium-dependent relaxation in internal mammary arteries used for coronary bypass surgery. Cardiovasc Res 1997; 34:568–74.
Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338:1546–50.
Jukema JW, Bruschke AV, van Boven AJ, et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 1995; 91:2528–40.
Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332:481–7.
Van Boven AJ, Jukema JW, Zwinderman AH, Crijns HJ, Lie Kl, Bruschke AV. Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group. Circulation 1996; 94:1503–5.
Rajagopalan S, Harrison DG. Reversing endothelial dysfunction with ACE inhibitors. A new trend. Circulation 1996; 94:240–3.
Mancini GB, Henry GC, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study [published erratum appears in: Circulation 1996; 94:1490]. Circulation 1996; 94:258–65.
Mulder P, Elfertak L, Richard V, et al. Peripheral artery structure and endothelial function in heart failure: effect of ACE inhibition. Am J Physiol 1996; 271:H469–77.
Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. A multicenter randomized trial. Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. JAMA 1997; 277:715–21.
Fischman DL, Leon MB, Bairn DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994; 331:496–501.
Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331:489–95.
Serruys PW, Emanuelsson HU, van der Giessen W, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. Circulation 1996; 93:412–22.
Bertrand ME, Lablanche JM, Fourrier JL, Gommeaux A, Ruel M. Relation to restenosis after percutaneous transluminal coronary angioplasty to vasomotion of the dilated coronary arterial segment. Am J Cardiol 1989; 63:277–81.
El Tamimi H, Davies GJ, Crea F, Maseri A. Response of human coronary arteries to acetylcholine after injury by coronary angioplasty. J Am Coll Cardiol 1993; 21:1152–7.
Weidinger FF, McLenachan JM, Cybulsky Ml, et al. Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery. Circulation 1990; 81:1667–79.
Jenkins JS, Webel R, Laughlin MH, et al. The effects of intravascular stents on vasomotion in porcine coronary arteries. J Invasive Cardiol 1995; 7:200–6.
Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:373–6.
Vanhoutte PM, Eber B. Endothelium-derived relaxing and contracting factors. Wien Klin Wochenschr 1991; 103:405–11.
Vanhoutte PM. Serotonin, hypertension and vascular disease. Neth Med 1991; 38:35–42.
Caramori PR, Lima VC, Seidelin PH, Newton GE, Adelman AG. Endothelial dysfunction distal to stents implanted for more than six months [abstract]. Circulation 1997; 96(8 Suppl):1756.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Monnink, S.H.J., Buikema, H., van Boven, A.J., van Gilst, W.H. (1998). Coronary Vascular Function in Stable and Unstable Angina. In: Van Der Wall, E.E., Blanksma, P.K., Niemeyer, M.G., Vaalburg, W., Crijns, H.J.G.M. (eds) Advanced Imaging In Coronary Artery Disease. Developments in Cardiovascular Medicine, vol 202. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0866-2_4
Download citation
DOI: https://doi.org/10.1007/978-94-007-0866-2_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-3746-4
Online ISBN: 978-94-007-0866-2
eBook Packages: Springer Book Archive